Cargando…

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression

The immunosuppressive tumor microenvironment represents not only one of the key factors stimulating tumor progression but also a strong obstacle for efficient tumor immunotherapy. Immunosuppression was found to be associated with chronic inflammatory mediators including cytokines, chemokines and gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Umansky, Viktor, Blattner, Carolin, Gebhardt, Christoffer, Utikal, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192356/
https://www.ncbi.nlm.nih.gov/pubmed/27827871
http://dx.doi.org/10.3390/vaccines4040036
_version_ 1782487758016610304
author Umansky, Viktor
Blattner, Carolin
Gebhardt, Christoffer
Utikal, Jochen
author_facet Umansky, Viktor
Blattner, Carolin
Gebhardt, Christoffer
Utikal, Jochen
author_sort Umansky, Viktor
collection PubMed
description The immunosuppressive tumor microenvironment represents not only one of the key factors stimulating tumor progression but also a strong obstacle for efficient tumor immunotherapy. Immunosuppression was found to be associated with chronic inflammatory mediators including cytokines, chemokines and growth factors produced by cancer and stroma cells. Long-term intensive production of these factors induces the formation of myeloid-derived suppressor cells (MDSCs) representing one of the most important players mediating immunosuppression. Moreover, MDSCs could not only inhibit anti-tumor immune reactions but also directly stimulate tumor growth and metastasis. Therefore, understanding the mechanisms of their generation, expansion, recruitment and activation is required for the development of novel strategies for tumor immunotherapy.
format Online
Article
Text
id pubmed-5192356
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-51923562017-01-03 The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression Umansky, Viktor Blattner, Carolin Gebhardt, Christoffer Utikal, Jochen Vaccines (Basel) Review The immunosuppressive tumor microenvironment represents not only one of the key factors stimulating tumor progression but also a strong obstacle for efficient tumor immunotherapy. Immunosuppression was found to be associated with chronic inflammatory mediators including cytokines, chemokines and growth factors produced by cancer and stroma cells. Long-term intensive production of these factors induces the formation of myeloid-derived suppressor cells (MDSCs) representing one of the most important players mediating immunosuppression. Moreover, MDSCs could not only inhibit anti-tumor immune reactions but also directly stimulate tumor growth and metastasis. Therefore, understanding the mechanisms of their generation, expansion, recruitment and activation is required for the development of novel strategies for tumor immunotherapy. MDPI 2016-11-03 /pmc/articles/PMC5192356/ /pubmed/27827871 http://dx.doi.org/10.3390/vaccines4040036 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Umansky, Viktor
Blattner, Carolin
Gebhardt, Christoffer
Utikal, Jochen
The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
title The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
title_full The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
title_fullStr The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
title_full_unstemmed The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
title_short The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
title_sort role of myeloid-derived suppressor cells (mdsc) in cancer progression
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192356/
https://www.ncbi.nlm.nih.gov/pubmed/27827871
http://dx.doi.org/10.3390/vaccines4040036
work_keys_str_mv AT umanskyviktor theroleofmyeloidderivedsuppressorcellsmdscincancerprogression
AT blattnercarolin theroleofmyeloidderivedsuppressorcellsmdscincancerprogression
AT gebhardtchristoffer theroleofmyeloidderivedsuppressorcellsmdscincancerprogression
AT utikaljochen theroleofmyeloidderivedsuppressorcellsmdscincancerprogression
AT umanskyviktor roleofmyeloidderivedsuppressorcellsmdscincancerprogression
AT blattnercarolin roleofmyeloidderivedsuppressorcellsmdscincancerprogression
AT gebhardtchristoffer roleofmyeloidderivedsuppressorcellsmdscincancerprogression
AT utikaljochen roleofmyeloidderivedsuppressorcellsmdscincancerprogression